Table 1. Relationships between FAM83H Expression and Clinicopathologic Features in Cervical Cancer Patients.
| Characteristics | Expression of FAM83H | ||
|---|---|---|---|
| Low | High | p value | |
| Age (yr) | 0.675 | ||
| <60 | 118 | 121 | |
| ≥60 | 34 | 31 | |
| Grade | 0.521 | ||
| G1+G2 | 75 | 78 | |
| G3 | 63 | 56 | |
| Clinical-stage | 0.008* | ||
| I+II | 127 | 104 | |
| III+IV | 24 | 42 | |
| Pathologic-T | 0.023* | ||
| T1+T2 | 117 | 94 | |
| T3+T4 | 10 | 20 | |
| Pathologic-N | 0.038* | ||
| N0 | 79 | 54 | |
| N1 | 26 | 34 | |
| Pathologic-M | 0.514 | ||
| M0 | 65 | 51 | |
| M1 | 7 | 3 | |
FAM83H, family with sequence similarity 83 member H.
Since the clinical pathological information was not complete in some cases, the number of cases in grade, Clinical-stage, Pathologic-T, N and M are less than 304, and the number of cases are different.
*p<0.05.